Prescription drug · ANDA
Ipratropium Bromide And Albuterol Sulfate NDC 50090-1382
Albuterol sulfate 2.5 mg/3mL; Ipratropium bromide .5 mg/3mL · Solution · Respiratory (Inhalation) · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-1382-0 | 50090138200 | 30 VIAL in 1 CARTON (50090-1382-0) / 3 mL in 1 VIALMarketed from Nov 28, 2014 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ipratropium Bromide And Albuterol Sulfate
- Generic name (nonproprietary)
- ipratropium bromide and albuterol sulfate
- Active ingredients
- Albuterol sulfate — 2.5 mg/3mLIpratropium bromide — .5 mg/3mL
- Dosage form
- Solution
- Route
- Respiratory (Inhalation)
- Labeler
- A-S Medication Solutions
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 202496
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta2-Agonists (Mechanism)Cholinergic Antagonists (Mechanism)
- Identifiers
- Product ID 50090-1382_d50406d8-cb32-45b6-be89-08fdab21fea9SPL ID d50406d8-cb32-45b6-be89-08fdab21fea9SPL set ID e452afc2-dc33-4be7-949e-143b2e5f530cRxCUI 1437702UNII 021SEF3731, J697UZ2A9J
- Pharmacologic class
- Anticholinergic; beta2-Adrenergic Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N450090138200followed by a unit qualifier and the quantityPackage 50090-1382-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Ipratropium Bromide and Albuterol Sulfate Inhalation Solution is indicated for the treatment of bronchospasm associated with COPD in patients requiring more than one bronchodilator.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 202496
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Ipratropium Bromide and Albuterol Sulfate | Ipratropium bromide .5 mg/3mL; Albuterol sulfate 2.5 mg/3mL | SolutionRespiratory (Inhalation) | Cipla USA Inc. | 69097-840 |
| Ipratropium Bromide And Albuterol Sulfate | Albuterol sulfate 2.5 mg/3mL; Ipratropium bromide .5 mg/3mL | SolutionRespiratory (Inhalation) | Golden State Medical Supply, Inc. | 60429-975 |
| Ipratropium Bromide and Albuterol Sulfate | Ipratropium bromide .5 mg/3mL; Albuterol sulfate 2.5 mg/3mL | SolutionRespiratory (Inhalation) | Mylan Pharmaceuticals Inc. | 0378-9671 |
| Ipratropium Bromide And Albuterol Sulfate | Albuterol sulfate 2.5 mg/3mL; Ipratropium bromide .5 mg/3mL | SolutionRespiratory (Inhalation) | American Health Packaging | 60687-405 |
| Ipratropium Bromide And Albuterol Sulfate | Albuterol sulfate 2.5 mg/3mL; Ipratropium bromide .5 mg/3mL | SolutionRespiratory (Inhalation) | Redpharm Drug | 67296-2315 |
| Ipratropium Bromide And Albuterol Sulfate | Albuterol sulfate 2.5 mg/3mL; Ipratropium bromide .5 mg/3mL | SolutionRespiratory (Inhalation) | Ritedose Pharmaceuticals, LLC | 76204-600 |